Loading chat...
IN HB1475
Bill
Status
1/18/2017
Primary Sponsor
Sheila Klinker
Click for details
AI Summary
-
State seed commissioner may adopt rules to implement industrial hemp laws after obtaining necessary federal permissions and waivers from the Drug Enforcement Agency.
-
State seed commissioner must apply for federal approvals before January 1, 2015, and file an affidavit with the governor within five days of waiver approval, with implementation to occur within 60 days thereafter.
-
Individuals with intractable epilepsy (seizure disorders unresponsive to other treatments) may legally possess and use cannabidiol oil containing no more than 0.3% THC and at least 15 times more CBD than THC, provided they have a physician's written recommendation.
-
Cannabidiol oil must be in containers of 32 fluid ounces or less with manufacturer labeling of THC content, CBD-to-THC ratio, and ingredients, verified by an independent laboratory unaffiliated with the producer.
-
Physicians who issue written recommendations for cannabidiol oil treatment of intractable epilepsy receive full civil, criminal, and administrative immunity for their recommendation, dispensing, possession, or administration of the substance.
Legislative Description
Industrial hemp. Allows the state seed commissioner to adopt rules to implement laws concerning industrial hemp. Encourages Indiana University School of Medicine and other state educational institutions to research the use of cannabidiol oil (CBD) from a hemp plant in the treatment of intractable epilepsy. Provides that an individual who possesses or uses CBD from a hemp plant for the treatment of intractable epilepsy is not subject to criminal penalties for the possession or use of the CBD if certain conditions are met. Provides civil, criminal, and administrative immunity for a physician who recommends, dispenses, possesses, or administers CBD in
Last Action
First reading: referred to Committee on Public Policy
1/18/2017